PODCAST-19: FiveThirtyEight on the Novel Coronavirus

A podcast by FiveThirtyEight, Anna Rothschild

46 Episodes

  1. Pandemics Don't Really End

    Published: 7/14/2021
  2. How The CDC's Blindspots Complicated The Fight Against COVID-19

    Published: 6/30/2021
  3. The Lab Leak Commotion

    Published: 6/2/2021
  4. Who Should Decide Who Gets To Make COVID-19 Vaccines?

    Published: 5/22/2021
  5. How To Make Sure Your Kid Isn't A Superspreader

    Published: 5/7/2021
  6. You Might Have Given The Coronavirus To Your Cat

    Published: 4/28/2021
  7. What A Donated Vaccine Can Do

    Published: 4/22/2021
  8. The Johnson & Johnson Pause Shows The System Is Working

    Published: 4/13/2021
  9. What The Heck Is Going On With AstraZeneca's Vaccine?

    Published: 3/26/2021
  10. How To Overcome Vaccine Hesitancy

    Published: 3/22/2021
  11. The COVID-19 Endemic

    Published: 3/6/2021
  12. How Variants Complicate Everything

    Published: 2/19/2021
  13. The Ethical Dilemmas Prompted By The Vaccine Rollout

    Published: 2/5/2021
  14. What Happens Once You Get An mRNA Vaccine

    Published: 1/15/2021
  15. Answering All (Or At Least Some) Of Your Vaccine Questions

    Published: 1/7/2021
  16. The Dr. Fauci Holiday Special

    Published: 12/22/2020
  17. Why Emily Oster Made Her Own COVID-19 Database

    Published: 12/11/2020
  18. How To Trust That A COVID-19 Vaccine Is Safe

    Published: 11/21/2020
  19. There's No Longterm Plan For Long COVID

    Published: 11/13/2020
  20. What To Make Of Pfizer's Big Vaccine Announcement

    Published: 11/10/2020

1 / 3

FiveThirtyEight's COVID-19 podcast is laser-focused on evidence. What do we know about the novel coronavirus, and what do we know we don't know? COVID-19 has pushed Americans into more uncertain territory than most have ever known. Our podcast helps listeners understand what they can be certain about, and what is still unknown. We investigate coronavirus mysteries, debate when it's safe to reopen the economy and keep track of the latest scientific developments on vaccines and treatments. We do it all with FiveThirtyEight's trademark blend of transparency and rigor.